APA 6th Edition

Fassbender, H.G. & Zorn, K. (2006). Oncological Proliferative Mechanisms in Rheumatoid Arthritis and Seronegative Spondylarthritides. Acta clinica Croatica, 45 (2), 129-130. Retrieved from https://hrcak.srce.hr/15440

---

MLA 8th Edition

Fassbender, Hans Georg and Kati Zorn. "Oncological Proliferative Mechanisms in Rheumatoid Arthritis and Seronegative Spondylarthritides." Acta clinica Croatica, vol. 45, no. 2, 2006, pp. 129-130. https://hrcak.srce.hr/15440. Accessed 18 May 2024.

---

Chicago 17th Edition

Fassbender, Hans Georg and Kati Zorn. "Oncological Proliferative Mechanisms in Rheumatoid Arthritis and Seronegative Spondylarthritides." Acta clinica Croatica 45, no. 2 (2006): 129-130. https://hrcak.srce.hr/15440

---

Harvard

Fassbender, H.G., and Zorn, K. (2006). 'Oncological Proliferative Mechanisms in Rheumatoid Arthritis and Seronegative Spondylarthritides', Acta clinica Croatica, 45(2), pp. 129-130. Available at: https://hrcak.srce.hr/15440 (Accessed 18 May 2024)

---

Vancouver

Fassbender HG, Zorn K. Oncological Proliferative Mechanisms in Rheumatoid Arthritis and Seronegative Spondylarthritides. Acta clinica Croatica [Internet]. 2006 [cited 2024 May 18];45(2):129-130. Available from: https://hrcak.srce.hr/15440

---

IEEE

H.G. Fassbender and K. Zorn, "Oncological Proliferative Mechanisms in Rheumatoid Arthritis and Seronegative Spondylarthritides", Acta clinica Croatica, vol.45, no. 2, pp. 129-130, 2006. [Online]. Available: https://hrcak.srce.hr/15440. [Accessed: 18 May 2024]